The Efficiency of Respiratory-gated 18F-FDG PET/CT in Lung Adenocarcinoma: Amplitude-gating Versus Phase-gating Methods

سال انتشار: 1396
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 240

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JNMB-5-1_004

تاریخ نمایه سازی: 12 تیر 1398

چکیده مقاله:

Objective(s): In positron emission tomography (PET) studies, thoracic movement under free-breathing conditions is a cause of image degradation. Respiratory gating (RG) is commonly used to solve this problem. Two different methods, i.e., phase-gating (PG) and amplitude-gating (AG) PET, are available for respiratory gating. It is important to know the strengths and weaknesses of both methods when selecting an RG methodfor a given patient. We conducted this study to clarify whether AG or PG is preferable for measuring fluorodeoxyglucose (FDG) accumulation in lung adenocarcinoma and to investigate patient conditions which are most suitable for AG and PG methods.Methods: A total of 31 patients (11 males, 20 females; average age: 11.6±70.1 yrs) with 44 lung lesions, diagnosed as lung adenocarcinoma between April 2012 and March 2013, were investigated. Whole-body FDG-PET/CT scan was performed with both PG and AG methods in all patients. The maximum standardized uptake value (SUVmax) of PG, AG, and the control data of these two methods were measured, and the increase ratio (IR), calculated as IR(%)= (Post – Pre)/Pre × 100, was calculated. The diameter and positionof lung lesions were also analyzed. We defined an ‘effective lesion’ of PG (or AG) as a lesion which showed a higher IR compared to AG (or PG). 8 (25.8%)Results: The average SUVmax and average IR were 7.94±8.99 and 25.6±21.4% in PG and 6.70±7.60 and 14.4±4.0% in AG, respectively. Although there was no significant difference between the average SUVmax of PG and AG (P=0.09), the average IR of PG was significantly higher than that of AG (P<0.01). The number of PG- and AG-effective lesions was 32 (72.7%) and 12 (28.3%) , respectively. There was no significant difference in the average diameter or position of the lesions between the PG- and AG-effective lesions.There were 23 (74.2%) PG-effective and 8 (25.8%) AG-effective patients. No significant difference was observed in sex or age between PG- and AG-effective patients.Conclusion: The PG method was more effective for measuring FDG accumulation of lung lesions under free-breathing conditions in comparison with the AG method.

نویسندگان

Yoshiyuki Kitamura

Department of Clinical Radiology, Kyushu University Hospital, Fukuoka, Japan

Shingo Baba

Department of Clinical Radiology, Kyushu University Hospital, Fukuoka, Japan

Takuro Isoda

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Yasuhiro Maruoka

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Osman MM, Cohade C, Nakamoto Y, Wahl RL. Respiratory motion ...
  • Nehmeh SA, Erdi YE, Lung CC, Rosenzweig KE, Squire OD, ...
  • Chang G, Chang T, Pan T, Clark JW Jr, Mawlwawi ...
  • Kawano T, Ohtake E, Inoue T. Deep-inspiration breath-hold PET/CT versus ...
  • García Vicente AM, Soriano Castrejón AM, Talavera Rubio MP, León ...
  • Knudtsen IS, Rødal J, Brustugun OT, Helland Å , Skretting ...
  • Werner MK, Parker JA, Kolodny GM, English JR, Palmer MR. ...
  • Lupi A, Zaroccolo M, Salgarello M, Malfatti V, Zanco P. ...
  • Grootjans W, de Geus-Oei LF, Meeuwis AP, van der Vos ...
  • Van Elmpt W, Hamill J, Jones J, De Ruysscher D, ...
  • Jani SS, Robinson CG, Dahlbom M, White BM, Thomas DH, ...
  • Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, ...
  • Committee Task Group. Radiation dose to patients from radiopharmaceuticals. Ann ...
  • Laffon E, de Clermont H, Lamare F, Marthan R. Estimating ...
  • نمایش کامل مراجع